|
137
|
423
|
6xcdA |
Structure of the c. botulinum neurotoxin serotype a light chain protease in complex with covalent inhibitor 22 |
|
142
|
424
|
7kz7A |
Crystals structure of the mutated protease domain of botulinum neurotoxin x (x4130b1). |
|
418
|
1290
|
2np0A |
Crystal structure of the botulinum neurotoxin type b complexed with synaptotagamin-ii ectodomain |
|
117
|
325
|
6mhjA |
Structure of bont mutant |
|
108
|
313
|
6dkkA |
Structure of bont |
|
129
|
438
|
6g5gA |
Crystal structure of an engineered botulinum neurotoxin type b mutant e1191m/s1199y in complex with human synaptotagmin 2 |
|
130
|
440
|
6g5fA |
Crystal structure of an engineered botulinum neurotoxin type b mutant e1191m/s1199y in complex with human synaptotagmin 1 |
|
107
|
433
|
6g5kA |
Crystal structure of the binding domain of botulinum neurotoxin type b in complex with human synaptotagmin 1 |
|
409
|
1295
|
3v0bA |
3.9 angstrom crystal structure of bont/ai in complex with ntnha |
|
408
|
1295
|
3v0aA |
2.7 angstrom crystal structure of bont/ai in complex with ntnha |
|
342
|
1295
|
3v0cA |
4.3 angstrom crystal structure of an inactive bont/a (e224q/r363a/y366f) |
|
401
|
1290
|
1i1eA |
Crystal structure of clostridium botulinum neurotoxin b complexed with doxorubicin |
|
401
|
1290
|
1g9bA |
Crystal structure of clostridium botulinum neurotoxin b complexed with an inhibitor (experiment 1) |
|
393
|
1290
|
1g9dA |
Crystal structure of clostridium botulinum neurotoxin b complexed with an inhibitor (experiment 2) |
|
405
|
1290
|
1g9cA |
Crystal structure of clostridium botulinum neurotoxin b complexed with an inhibitor (experiment 4) |
|
395
|
1290
|
1g9aA |
Crystal structure of clostridium botulinum neurotoxin b complexed with an inhibitor (experiment 3) |
|
136
|
421
|
5vgxA |
Structure of the c. botulinum neurotoxin serotype a with hg bound |
|
103
|
423
|
5moyA |
Crystal structure of the bont/a2 receptor-binding domain in complex with the luminal domain of its neuronal receptor sv2c |
|
116
|
421
|
5mk6A |
Crystal structure of the receptor-binding domain of botulinum neurotoxin a1 (crystal form 1) |
|
103
|
410
|
5mk7A |
Crystal structure of the receptor-binding domain of botulinum neurotoxin a1 (crystal form 2) |
|
99
|
421
|
5lr0A |
Binding domain of botulinum neurotoxin dc in complex with sialylt |
|
117
|
428
|
5l21A |
Crystal structure of bont/a receptor binding domain in complex with vhh c2 |
|
117
|
427
|
5jlvA |
Receptor binding domain of botulinum neurotoxin a in complex with human glycosylated sv2c |
|
113
|
431
|
5jmcA |
Receptor binding domain of botulinum neurotoxin a in complex with rat sv2c |
|
112
|
420
|
6es1A |
Crystal structure of the binding domain from botulinum neurotoxin a2 bound to extracellular domain of human receptor sv2c |
|
107
|
420
|
6f0oA |
Botulinum neurotoxin a3 hc domain |
|
135
|
421
|
5vgvA |
Structure of the c. botulinum neurotoxin serotype a with cu bound |
|
113
|
431
|
5vmrA |
Receptor binding domain of bont/b in complex with mini-protein binder bot.2110.4 |
|
96
|
429
|
5vidA |
Receptor binding domain of bont/b in complex with mini-protein binder bot.0671.2 |
|
271
|
871
|
5bqnA |
Crystal structure of the lhn fragment of botulinum neurotoxin type d, mutant h233y e230q |
|
302
|
1251
|
4zktA |
Crystal structure of the progenitor m complex of clostridium botulinum type e neurotoxin |
|
100
|
403
|
5bqmB |
Crystal structure of sxn101959, a clostridium botulinum neurotoxin type d derivative and targeted secretion inhibitor |
|
148
|
433
|
4ej5A |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a wild-type |
|
144
|
433
|
4elcA |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134 mutant with mtsea modified cys-165 |
|
147
|
425
|
4el4A |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s/c165s double mutant |
|
275
|
913
|
3zusA |
Crystal structure of an engineered botulinum neurotoxin type a- snare23 derivative, lc-a-snap23-hn-a |
|
273
|
892
|
3zuqA |
Crystal structure of an engineered botulinum neurotoxin type b - derivative, lc-b-gs-hn-b |
|
280
|
944
|
3zurA |
Crystal structure of an engineered botulinum neurotoxin type a- snare23 derivative, lc0-a-snap25-hn-a |
|
105
|
413
|
3rsjA |
Structure of hcrf in complex with ganglioside gd1a |
|
89
|
415
|
3rmxA |
Crystal structure of hcr/d f1240a mutant |
|
97
|
415
|
3rmyA |
Crystal structure of hcr/d w1238a mutant |
|
121
|
426
|
5v8pA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
127
|
426
|
5v8uA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
133
|
430
|
5v8rA |
Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain |
|
104
|
424
|
5tpbA |
Binding domain of bont/a complexed with ganglioside variant |
|
110
|
425
|
5tpcA |
Binding domain of bont/a complexed with ganglioside |
|
135
|
423
|
4zjxA |
Crystal structure of the catalytic domain of botulinum neurotoxin serotype a with a novel cyclic peptide inhibitor |
|
117
|
442
|
5bqmA |
Crystal structure of sxn101959, a clostridium botulinum neurotoxin type d derivative and targeted secretion inhibitor |
|
132
|
428
|
4ktxA |
Crystal structure of the catalytic domain of botulinum neurotoxin bont/a c134s mutant with covalent inhibitor that modifies cys-165 causing disorder in 167-174 stretch |
|
103
|
430
|
4kbbA |
Structure of botulinum neurotoxin b binding domain in complex with both synaptotagmin ii and gd1a |
